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Daily consumption of 3 g oat b-glucan is considered sufficient to lower serum LDL cholesterol (LDL-C), but not all studies show an
effect. The ability of oat b-glucan to reduce LDL-C is thought to depend on viscosity which is controlled by the molecular weight (MW)
and the amount of oat b-glucan solubilized in the intestinal lumen (C), but this has not been demonstrated in human subjects.
Therefore, our two primary objectives were to determine if consuming 3 g high-MW oat-b-glucan daily reduced LDL-C, and if LDL-C-
lowering was related to log(MW · C) of oat-b-glucan. To address these objectives, we conducted a randomized, controlled, double-blind
parallel design clinical trial in two contract–research–organisations and three university nutrition research centres in Canada, Australia and
UK. A volunteer sample of healthy subjects with LDL-C ‡3.0 and £5.0 mmol/l (n 786 screened, n 400 ineligible, n 19 refused, n 367
randomized, n 345 completed) were randomly assigned by the computer to receive one of five treatments. Subjects consumed cereal
containing wheat fibre (n 87) or a total of 3 g high-MW (n 86), 4 g medium-MW (n 67), 3 g medium-MW (n 64) or 4 g low-MW (n 63) oat
b-glucan daily (OatWell1, divided doses, twice-daily) for 4 weeks. Using an intent-to-treat analysis, serum-LDL-C concentration after
4 weeks was compared between treatments after adjusting for baseline LDL-C.
After 4 weeks, LDL-C on 3 g high-MW oat b-glucan cereal was less than on wheat-fibre cereal by 0.21 mmol/l (95% CI; - 0.11,
- 0.30, P = 0.0023). By analysis of covariance log(MW · C) was a significant determinant of week 4 LDL-C-cholesterol (P = 0.003). The
treatment effect was not significantly influenced by age, sex, study centre or baseline LDL-C.
It was concluded that consuming only 3 g high-MW oat b-glucan daily in a ready-to-eat cereal reduced LDL-C by 0.2 mmol/l; efficacy
was reduced in cereals containing oat b-glucan with low MW. Thus, the physicochemical properties of oat b-glucan should be considered
when assessing the cholesterol-lowering ability of oat-containing products.
The trial was registered at www.clinicaltrials.gov NCT00981981.
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